로그인

Yu-An Zhang

Department of Internal Medicine,
Division of Hematology and Oncology,
Harold C. Simmons Comprehensive Cancer Center,
Department of Internal Medicine, Division of Hematology and Oncology

University of Texas Southwestern Medical Center

BIOGRAPHY

Yu-An Zhang has not added Biography.

If you are Yu-An Zhang and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Frequent detection of infectious xenotropic murine leukemia virus (XMLV) in human cultures established from mouse xenografts.

Cancer biology & therapy Oct, 2011 | Pubmed ID: 21750403

EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk.

Oncogene Sep, 2014 | Pubmed ID: 24096489

Validation of SCT Methylation as a Hallmark Biomarker for Lung Cancers.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Mar, 2016 | Pubmed ID: 26725182

ITPKA Gene Body Methylation Regulates Gene Expression and Serves as an Early Diagnostic Marker in Lung and Other Cancers.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 09, 2016 | Pubmed ID: 27234602

SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.

EBioMedicine Nov, 2016 | Pubmed ID: 27840009

Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes.

Translational lung cancer research Feb, 2018 | Pubmed ID: 29535911

Inhalational delivery of induced pluripotent stem cell secretome improves postpneumonectomy lung structure and function.

Journal of applied physiology (Bethesda, Md. : 1985) 11, 2020 | Pubmed ID: 32909918

SCT Promoter Methylation is a Highly Discriminative Biomarker for Lung and Many Other Cancers.

IEEE life sciences letters Oct, 2015 | Pubmed ID: 33758771

Constitutive transgenic α-Klotho overexpression enhances resilience to and recovery from murine acute lung injury.

American journal of physiology. Lung cellular and molecular physiology 10, 2021 | Pubmed ID: 34346778

INSTITUTIONS

University of Texas Southwestern Medical Center

JOVE ARTICLES

Generating and Imaging Mouse and Human Epithelial Organoids from Normal and Tumor Mammary Tissue Without Passaging

Serena L. Cornelius^1,2,

Megan M. Colonnetta^2,3,4,5,

Katherine E. Lake^1,2,

Clayton A. Smith^1,2,

Yu-An Zhang^1,2,

Evanthia T. Roussos-Torres⁶,

Sangeetha M. Reddy^1,2,

Elizabeth H. Chen^2,3,4,5,

Isaac S. Chan^1,2,3,4

¹Department of Internal Medicine, Division of Hematology and Oncology, University of Texas Southwestern Medical Center,

²Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center,

³Department of Molecular Biology, University of Texas Southwestern Medical Center,

⁴Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center,

⁵Department of Cell Biology, University of Texas Southwestern Medical Center,

⁶Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California

Cancer Research

개인 정보 보호

이용 약관

정책

연락처

사서에게 추천하기

JoVE 뉴스레터

연구

JoVE Journal
연구 방법 컬렉션
JoVE Encyclopedia of Experiments
아카이브

교육

JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Business
JoVE Quiz
JoVE Playlist
Faculty Site

저자

개요
간행과정
편집 위원회
범위 및 정책
Peer Review
자주하는 질문
제출

사서

개요
추천의 글
구독
액세스
리소스
라이브러리 자문 위원회
자주하는 질문

JoVE 소개

개요
리더십
블로그
JoVE Help Center
JoVE Sitemap

당사 웹 사이트에서는 사용자의 경험을 향상시키기 위해 쿠키를 사용합니다.

당사 웹 사이트를 계속 사용하거나 '계속'을 클릭하는 것은 당사 쿠키 수락에 동의하는 것을 의미합니다.

더 알아보기

Yu-An Zhang

Department of Internal Medicine,Division of Hematology and Oncology,Harold C. Simmons Comprehensive Cancer Center,Department of Internal Medicine, Division of Hematology and Oncology

University of Texas Southwestern Medical Center

Generating and Imaging Mouse and Human Epithelial Organoids from Normal and Tumor Mammary Tissue Without Passaging

Department of Internal Medicine,
Division of Hematology and Oncology,
Harold C. Simmons Comprehensive Cancer Center,
Department of Internal Medicine, Division of Hematology and Oncology